<h1>Indian Pharma Exports Soar 103% from 2013-14 to 2021-22, Surpassing Rs. 1,83,422 Crores Despite Global Challenges.</h1> India's pharmaceutical exports have grown by 103% from 2013-14 to 2021-22, reaching Rs. 1,83,422 Crores. This growth marks the sector's best export performance, with a trade surplus of USD 15,175.81 million. Despite global trade disruptions, Indian pharma exports maintained positive growth, with 55% catering to regulated markets. India supplies 60% of the world's vaccines and 20% of generic medicines, ranking third in production volume. The industry benefits from manufacturing excellence, cost-competitiveness, and innovation. Major export destinations include the USA, UK, and South Africa. India also developed COVID-19 vaccines and signed trade agreements with the UAE and Australia.